Product Description: p53 (232-240) is a peptide segment of the 232-240 amino acid sequence of the human tumor suppressor protein p53. p53 (232-240) enhances its binding affinity to the Major histocompatibility complex (MHC), thereby enhancing the immunogenicity of this peptide to enhance the immune system's response to tumor antigens. p53 (232-240) can be used in the development of cancer vaccines and in the study of tumor cell recognition and clearance by the immune system[1].
Formula: C41H67N11O14S4
References: [1]Baratin M, et al. Amino acid modifications in the wild type sequence p53 232–240 overcome the poor immunogenicity of this self tumour epitope[J]. Journal of Peptide Science: An Official Publication of the European Peptide Society, 2002, 8(7): 327-334.
CAS Number: 155314-26-4
Molecular Weight: 1066.30
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Others
English
Deutsch
